Inside Eli Lilly's $1.2 Billion Deal with Ventyx Biosciences

from Prestons Super Show · host Preston Olson

Eli Lilly Purchases Ventyx Biosciences for $1.2 billion. Ventyx Biosciences is advancing a gallimaufry of treatments. Including but not limited to, oral therapies for inflammatory bowel diseases. Thank you for listening. Visit myoddman.com and subscribe for more! Super News #122.

Episode metadata supplied by the publisher feed · Published Jan 8, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Inside Eli Lilly's $1.2 Billion Deal with Ventyx Biosciences

0:00 1:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Prestons Super Show?

This episode is 1 minute long.

When was this Prestons Super Show episode published?

This episode was published on January 8, 2026.

Can I download this Prestons Super Show episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!